127 related articles for article (PubMed ID: 38328235)
1. Computation-aided Design of Rod-Shaped Janus Base Nanopieces for Improved Tissue Penetration and Therapeutics Delivery.
Lee J; Zhang W; Nguyen D; Zhou L; Amengual J; Zhai J; Cote T; Landolina M; Ahmadi E; Sands I; Mishra N; Yu H; Nieh MP; Wang K; Li Y; Chen Y
bioRxiv; 2024 Jan; ():. PubMed ID: 38328235
[TBL] [Abstract][Full Text] [Related]
2. RNA Delivery via DNA-Inspired Janus Base Nanotubes for Extracellular Matrix Penetration.
Sands I; Lee J; Zhang W; Chen Y
MRS Adv; 2020; 5(16):815-823. PubMed ID: 32405433
[TBL] [Abstract][Full Text] [Related]
3. DNA-inspired nanomaterials for enhanced endosomal escape.
Lee J; Sands I; Zhang W; Zhou L; Chen Y
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33941681
[TBL] [Abstract][Full Text] [Related]
4. Cancer Cell Membrane-Camouflaged Nanorods with Endoplasmic Reticulum Targeting for Improved Antitumor Therapy.
Zhang W; Yu M; Xi Z; Nie D; Dai Z; Wang J; Qian K; Weng H; Gan Y; Xu L
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46614-46625. PubMed ID: 31747243
[TBL] [Abstract][Full Text] [Related]
5. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
[TBL] [Abstract][Full Text] [Related]
7. Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.
Cong VT; Gaus K; Tilley RD; Gooding JJ
Expert Opin Drug Deliv; 2018 Sep; 15(9):881-892. PubMed ID: 30173560
[TBL] [Abstract][Full Text] [Related]
8. Icebreaker-inspired Janus nanomotors to combat barriers in the delivery of chemotherapeutic agents.
Zhang Z; Zhang D; Qiu B; Cao W; Liu Y; Liu Q; Li X
Nanoscale; 2021 Apr; 13(13):6545-6557. PubMed ID: 33885534
[TBL] [Abstract][Full Text] [Related]
9. Novel Ionizable Lipid Nanoparticles for SARS-CoV-2 Omicron mRNA Delivery.
Long J; Yu C; Zhang H; Cao Y; Sang Y; Lu H; Zhang Z; Wang X; Wang H; Song G; Yang J; Wang S
Adv Healthc Mater; 2023 May; 12(13):e2202590. PubMed ID: 36716702
[TBL] [Abstract][Full Text] [Related]
10. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
Francia V; Schiffelers RM; Cullis PR; Witzigmann D
Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
[TBL] [Abstract][Full Text] [Related]
11. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
Wang X; Zhang W; Zeng S; Wang L; Wang B
Acta Biomater; 2024 Feb; 175():262-278. PubMed ID: 38141933
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.
Xu Y; Ou M; Keough E; Roberts J; Koeplinger K; Lyman M; Fauty S; Carlini E; Stern M; Zhang R; Yeh S; Mahan E; Wang Y; Slaughter D; Gindy M; Raab C; Thompson C; Hochman J
Mol Pharm; 2014 May; 11(5):1424-34. PubMed ID: 24588618
[TBL] [Abstract][Full Text] [Related]
13. Drug discovery efforts at George Mason University.
Andalibi A; Veneziano R; Paige M; Buschmann M; Haymond A; Espina V; Luchini A; Liotta L; Bishop B; Van Hoek M
SLAS Discov; 2023 Sep; 28(6):270-274. PubMed ID: 36921802
[TBL] [Abstract][Full Text] [Related]
14. Lipid Nanoparticle Spherical Nucleic Acids for Intracellular DNA and RNA Delivery.
Sinegra AJ; Evangelopoulos M; Park J; Huang Z; Mirkin CA
Nano Lett; 2021 Aug; 21(15):6584-6591. PubMed ID: 34286581
[TBL] [Abstract][Full Text] [Related]
15. Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy.
Kim J; Song S; Gwak M; Cho H; Yun WS; Hwang N; Kim J; Lee JS; Kim DH; Kim H; Jeon SI; Kim TI; Kim K
Biomater Res; 2023 Oct; 27(1):102. PubMed ID: 37845762
[TBL] [Abstract][Full Text] [Related]
16. Current issues of RNAi therapeutics delivery and development.
Haussecker D
J Control Release; 2014 Dec; 195():49-54. PubMed ID: 25111131
[TBL] [Abstract][Full Text] [Related]
17. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique
Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ
Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076
[TBL] [Abstract][Full Text] [Related]
18. Computational and Experimental Approaches to Investigate Lipid Nanoparticles as Drug and Gene Delivery Systems.
Chan C; Du S; Dong Y; Cheng X
Curr Top Med Chem; 2021; 21(2):92-114. PubMed ID: 33243123
[TBL] [Abstract][Full Text] [Related]
19. Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics.
Leong EWX; Ge R
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140280
[TBL] [Abstract][Full Text] [Related]
20. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
